HACKENSACK, N.J. (April 26, 2010, 4 p.m. EDT) — Myelodysplastic syndromes (MDS) — a group of serious blood cancers — are nearly five times more common in seniors than previously thought, according to ...

Myelodysplastic syndromes (MDS) are a group of blood cancers in which the bone marrow fails to produce enough healthy blood ...

Bagully’s success on nicotinamide riboside prompted Maria Amaya, MD, PhD, to study the supplement’s effects in others with ...

Tetsuya Chiba, the manga artist behind Ashita no Joe, has died at 87. Many fans are asking, “Is Tetsuya Chiba still alive?” ...

Smoking may contribute to genetic mutations and disease progression in myelodysplastic syndromes, a recent study found. Results from a recent study showed that, in patients with myelodysplastic ...

Personalized treatment strategies are increasingly important in managing lung cancer brain metastases, incorporating targeted therapies and immunotherapies. Stereotactic radiosurgery and whole-brain ...

Myelodysplastic syndromes (MDS) belong to the malignant diseases of the hematopoietic system that occur primarily in older adults. In patients with MDS, blood formation in bone marrow is impaired.

Image courtesy of the U.S. Centers for Disease Control. Over the past 50 years, survival rates for a group of blood cancers known as myelodysplastic syndrome (MDS) have not improved, despite the ...

Oral vitamin C improved OS in patients with CCUS or lower-risk myeloid malignancies in the EVITA trial despite missing the clonal growth primary end point. Although the phase 2 EVITA trial ...

A Bristol Myers drug that treats anemia caused by a type of blood cancer now has an FDA approval that moves it up in the hierarchy of treatments, expanding the eligible patient population and ...